# EDGAR Filing Document

**Accession Number:** 0001851182
**File Stem:** 0001104659-23-008801
**Filing Date:** 2023-2
**Character Count:** 8551
**Document Hash:** d9870f4111861abc708e29e1c4fa330a
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001104659-23-008801.hdr.sgml**: 20230201

**ACCESSION NUMBER**: 0001104659-23-008801

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 14

**CONFORMED PERIOD OF REPORT**: 20230131

**ITEM INFORMATION**: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year

**ITEM INFORMATION**: Submission of Matters to a Vote of Security Holders

**ITEM INFORMATION**: Financial Statements and Exhibits

**FILED AS OF DATE**: 20230201

**DATE AS OF CHANGE**: 20230131

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Future Health ESG Corp.
- **CENTRAL INDEX KEY:** 0001851182
- **STANDARD INDUSTRIAL CLASSIFICATION:** BLANK CHECKS [6770]
- **IRS NUMBER:** 862305680
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-40788
- **FILM NUMBER:** 23574164

**BUSINESS ADDRESS:**
- **STREET 1:** 8 THE GREEN
- **STREET 2:** SUITE # 12081
- **CITY:** DOVER
- **STATE:** DE
- **ZIP:** 19901
- **BUSINESS PHONE:** 833-388-8734

**MAIL ADDRESS:**
- **STREET 1:** 8 THE GREEN
- **STREET 2:** SUITE # 12081
- **CITY:** DOVER
- **STATE:** DE
- **ZIP:** 19901

?xml version="1.0" encoding="utf-8"?

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**FORM 8-K**

**CURRENT REPORT**

**PURSUANT TO SECTION 13 OR 15(d)**

**OF THE SECURITIES EXCHANGE ACT OF 1934**

**Date of Report (Date of earliest event reported): January 31, 2023 (January 31, 2023)**

**Future Health ESG Corp.**

**(Exact name of registrant as specified in its charter)**

---

| | | |
|:---|:---|:---|
| **Delaware** | **001-40788** | **86-2305680** |
| **(State or other jurisdiction<br> of incorporation)** | **(Commission<br> File Number)** | **(IRS Employer<br> Identification No.)** |

---

**8 The Green, Suite 12081**

**Dover, DE 19901**

**(Address of principal executive offices, including zip code)**

**(Registrant's telephone number, including area code): (833) 388-8734**

**Not Applicable**

**(Former name or former address, if changed since last report)**

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| **Title of each class** | **Trading Symbol(s)** | **Name of each exchange on which registered** |
| **Units, each consisting of one share of common stock and one-half of one redeemable Warrant** | **FHLTU** | **The Nasdaq Stock Market LLC** |
| **Common stock, par value $0.0001 per share** | **FHLT** | **The Nasdaq Stock Market LLC** |
| **Redeemable warrants, each whole warrant exercisable for one share of common stock at an exercise price of $11.50 per share** | **FHLTW** | **The Nasdaq Stock Market LLC** |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ⌧

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ◻

---

| | |
|:---|:---|
| **Item 5.03.** | **Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.** |

---

On January 31, 2023, Future Health ESG Corp., a Delaware corporation (the "**Company**"), held a special meeting of stockholders (the "**Meeting**"). At the Meeting, the Company's stockholders approved an amendment (the "**Charter Amendment**") to the Company's Amended and Restated Certificate of Incorporation to decrease the number of authorized shares of common stock, par value $0.0001 per share, from 500,000,000 to 26,000,000. On January 31, 2023, the Company filed a copy of the Charter Amendment with the Secretary of State of the State of Delaware. A copy of the Charter Amendment is attached as Exhibit 3.1 hereto and is incorporated herein by reference.

---

| | |
|:---|:---|
| **Item 5.07.** | **Submission of Matters to a Vote of Security Holders.** |

---

At the Meeting, the Company's stockholders approved the Charter Amendment to decrease the number of authorized shares of common stock, par value $0.0001 per share, from 500,000,000 to 26,000,000 (the "**Charter Amendment Proposal**").

The final voting results for the Charter Amendment Proposal were as follows:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **For** | **For** | **Against** | **Against** | **Abstain** | **Abstain** |
|  | 4802623 |  | 0 |  | 0 |

---

---

| | |
|:---|:---|
| **Item 9.01** | **Financial Statements and Exhibits.** |

---

&nbsp;&nbsp;&nbsp;&nbsp;(d) Exhibits. The following exhibits are filed with this Form 8-K:

---

| | |
|:---|:---|
| **Exhibit No.** | **Description of Exhibits** |
| [3.1](tm235069d1_ex3-1.htm) | [Second Amendment to the Amended and Restated Certificate of Incorporation, filed on January 31, 2023.](tm235069d1_ex3-1.htm) |
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document). |

---

**SIGNATURE**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Dated: January 31, 2023

---

| | |
|:---|:---|
| **FUTURE HEALTH ESG CORP.** | **FUTURE HEALTH ESG CORP.** |
| By: | /s/ Bradley A. Bostic |
| Name: | Bradley A. Bostic |
| Title: | Chief Executive Officer |

---

## Exhibit 3.1

**Exhibit 3.1**

**SECOND CERTIFICATE OF AMENDMENT TO THE<br> AMENDED AND RESTATED<br> CERTIFICATE OF INCORPORATION<br> OF<br> FUTURE HEALTH ESG CORP.**

Future Health ESG Corp., a corporation organized and existing under and by virtue of the General Corporation Law of the State of Delaware (the "DGCL"), does hereby certify:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1. The name of the corporation is Future Health ESG Corp. The corporation was originally incorporated pursuant to the DGCL on February 25, 2021, under the name of Future Health ESG Corp.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2. The date of filing of the corporation's original Certificate of Incorporation with the Secretary of State of the State of Delaware was February 25, 2021, the date of filing the corporation's Amended and Restated Certificate of Incorporation with the Secretary of State of the State of Delaware was September 9, 2021 and the date of filing the corporation's Certificate of Amendment to the Amended and Restated Certificate of Incorporation was December 9, 2022.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3. The Board of Directors of the corporation has duly adopted resolutions setting forth proposed amendments to the Certificate of Incorporation of the corporation (as amended and restated prior to the date hereof), declaring said amendment to be advisable and in the best interests of the corporation and its stockholders and authorizing the appropriate officers of the corporation to solicit the consent of the stockholders therefor, which resolutions setting forth the proposed amendment are substantially as follows:

**RESOLVED,** that Section 4.1 of the Amended and Restated Certificate of Incorporation of the corporation is amended and restated to read in its entirety as follows:

"Authorized Capital Stock. The total number of shares of all classes of capital stock, each with a par value of $0.0001 per share, which the Corporation is authorized to issue is 31,000,000, consisting of (a) 26,000,000 shares of common stock (the "Common Stock"), and (b) 5,000,000 shares of preferred stock (the "Preferred Stock")."

**IN WITNESS WHEREOF**, the corporation has caused this Certificate of Amendment to be signed this 31st day of January, 2023.

---

| |
|:---|
| /s/ Bradley A. Bostic |
| Bradley A. Bostic |
| Chief Executive Officer |

---